Predictions
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.74
20.02.22
20.02.22
€30.00
20.03.22
20.03.22
2.76%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Novocure Ltd
Start price
Target price
Perf. (%)
€59.26
09.01.22
09.01.22
€51.00
09.01.23
09.01.23
8.34%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.05
09.03.21
09.03.21
€28.00
09.03.22
09.03.22
15.36%
10.03.22
10.03.22
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€27.30
16.02.22
16.02.22
-
16.02.23
16.02.23
-5.71%
20.02.22
20.02.22
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€6.22
06.02.22
06.02.22
-
06.02.23
06.02.23
-15.28%
20.02.22
20.02.22
Risky Investment
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.89
07.02.22
07.02.22
-
07.02.23
07.02.23
-0.58%
20.02.22
20.02.22
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€27.30
16.02.22
16.02.22
-
16.02.23
16.02.23
-5.71%
19.02.22
19.02.22
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.86
16.02.22
16.02.22
-
16.02.23
16.02.23
-5.96%
19.02.22
19.02.22
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€81.32
16.02.22
16.02.22
-
16.02.23
16.02.23
-1.25%
19.02.22
19.02.22
Risky Investment
Nektar Therapeutics
Start price
Target price
Perf. (%)
€9.30
02.02.22
02.02.22
-
02.02.23
02.02.23
-2.26%
06.02.22
06.02.22
Risky Investment
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.52
01.02.22
01.02.22
-
01.02.23
01.02.23
-12.69%
06.02.22
06.02.22
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€98.42
25.01.21
25.01.21
€100.00
25.01.22
25.01.22
-30.50%
26.01.22
26.01.22
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€81.19
24.01.21
24.01.21
€140.00
24.01.22
24.01.22
30.56%
15.01.22
15.01.22
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment
Arena Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€81.50
13.12.21
13.12.21
-
13.12.22
13.12.22
1.23%
06.01.22
06.01.22
Probably not worthwhile Investment